Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Matico leaf (Piper aduncum) contains up to 76% dillapiol in its essential oil alongside β-caryophyllene, nerolidol, and piperitone, which collectively confer potent analgesic, antimicrobial, gastroprotective, and antioxidant activity through multiple pharmacological pathways including GPIIb/IIIa integrin inhibition and PLC-γ2 suppression. A controlled study in rats demonstrated that a Piper aduncum phytochemical preparation produced significant gastroprotective and antisecretory effects comparable to omeprazole (PMID 24448937), while separate research confirmed its antioxidant cytoprotective capacity against sodium fluoride–induced toxicity in albino mice (PMID 31100918).
Reported Benefits (Provisional)
Origin & History
Matico Leaf (Piper aduncum) is native to the Amazon rainforest, found particularly in Peru, Ecuador, and Colombia. This revered botanical thrives in its humid, tropical environment. Known as the "soldier's herb," it has been a cornerstone of Amazonian traditional medicine for its potent healing and protective properties.
Research Narrative (Provisional)
Arroyo et al. (2013) demonstrated in a rat model that a phytochemical preparation from Piper aduncum leaves exerted gastroprotective and antisecretory effects, significantly reducing gastric lesions and acid secretion (Rev Peru Med Exp Salud Publica, PMID 24448937). Backhouse et al. (2008) confirmed the antinociceptive activity of Buddleja globosa (Chilean matico) across multiple pain models in mice, including acetic acid writhing, hot plate, and formalin tests, supporting traditional analgesic use (J Ethnopharmacol, PMID 18639621). Herrera-Calderon et al. (2019) showed that Piper aduncum extract provided antioxidant and cytoprotective effects against sodium fluoride–induced hepatic and renal toxicity in albino mice, with dose-dependent reductions in oxidative stress markers (Toxics, PMID 31100918). Rafael-Saldaña et al. (2025) optimized ultrasound-assisted extraction of bioactive compounds from Piper aduncum leaves, identifying phenolics and flavonoids as key contributors to antioxidant capacity (Molecules, PMID 41302453).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Flavonoids, Polyphenols, Essential Oils, Tannins, Saponins, Alkaloids (antimicrobial, anti-inflammatory) - Vitamins: B-complex (Thiamine, Riboflavin, Niacin) - Minerals: Potassium, Magnesium, Calcium, Iron
Reported Mechanism (Provisional)
Dillapiol, the predominant essential oil constituent (up to 76%), inhibits platelet aggregation by suppressing GPIIb/IIIa integrin activation and blocking downstream phosphorylation of PLC-γ2 and PKC-β2, thereby reducing thromboxane A2 formation and intracellular calcium mobilization. β-Caryophyllene acts as a selective CB2 cannabinoid receptor agonist, attenuating NF-κB nuclear translocation and reducing pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), which underlies matico's analgesic and anti-inflammatory effects demonstrated in formalin and acetic acid pain models (PMID 18639621). The gastroprotective mechanism involves reduction of basal gastric acid secretion and enhancement of mucosal prostaglandin synthesis, paralleling proton pump inhibitor activity as shown in the rat ulcer model (PMID 24448937). Additionally, phenolic compounds and flavonoids scavenge reactive oxygen species via NADPH oxidase modulation and upregulation of endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase), conferring the cytoprotective effects observed against fluoride-induced organ toxicity (PMID 31100918).
Clinical Narrative (Provisional)
Primary clinical evidence derives from in vitro platelet studies demonstrating concentration-dependent antiplatelet effects at 0.01-1 mg/mL, with strongest inhibition against collagen-induced aggregation. Antifungal research shows dillapiol efficacy at 1 part per million concentrations, with potency comparable to fluconazole for dermatophyte infections. Traditional use studies document application for peptic ulcers and gastrointestinal disorders, though large-scale human clinical trials with specific participant numbers and standardized dosing protocols remain limited. Current evidence consists primarily of preclinical and small-scale observational studies requiring validation through randomized controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.